Summary: JPMorgan adds Biopharma, Medtech insights

Why It Matters: JPMorgan is sharing new insights about the biopharma and medtech industries. This shows they are focusing on these areas.

What Changed:

• A new insight titled "Biopharma, medtech activity diverges in Q3 2025" was added.
• The category for this insight changed from "Banking" to "Markets and Economy".
• The previous insight "Q3 2025 venture capital trends in Europe" was removed.